National Institute for Health and Clinical Excellence (NICE)
Shared Learning Awards 2020: Winner announced
Virtual ceremony sees a project from Avon and Wiltshire Mental Health Partnership Trust voted winning submission.
NICE is delighted to announce the winner of this year’s Shared learning Awards – a project that successfully implemented guidelines to improve the outcomes for patients during a first episode of psychosis.
The awards, which took place last month, recognise where health and care practitioners have put NICE guidance into practice to improve outcomes and services for the people they serve.
This year, due to the ongoing pandemic, the NICE Shared Learning awards ceremony was held virtually.
Professor Gillian Leng, NICE chief executive, said: “The Shared Learning Awards provide an opportunity to hear first-hand from those who are successfully using our guidance to help improve the quality, safety and equity of care. The ongoing pandemic makes it essential that we continue to collaborate to ensure better outcomes for those using the healthcare system.”
Prescribing guidelines for patients with a first episode of psychosis, a project from Avon and Wiltshire Mental Health Partnership Trust (AWP) aimed at improving prescribing practice and ensuring the right medication is provided at the right time for people in the first stage of psychosis, was voted the 2020 winner of the NICE Shared Learning Awards.
The AWP serves a population of approximately 1.8 million people. Prescribing greatly varied for patients with a first episode of psychosis. After seeing this happen, using NICE guidance ‘Psychosis and schizophrenia in adults’ (CG178) and ‘Psychosis and schizophrenia in children and young people’ (CG155), Early Intervention in Psychosis teams across the AWP wanted to develop clear guidance for prescribers of people with a first episode of psychosis to ensure evidence-based best practice.
Dr Liz Ewins, consultant psychiatrist for Bath and North East Somerset Early Intervention in Psychosis Team, Avon & Wiltshire Mental Health Partnership NHS Trust, yesterday said:
“We are thrilled to have won the NICE Shared Learning award 2020 in recognition of our work to improve prescribing for patients with a first episode of psychosis. This has been a fantastic opportunity to share our learning with others. We have been able to raise the importance of early intervention, and the huge impact that appropriate early treatment can have on mental health.
“With input from the whole multidisciplinary team and Early Intervention in Psychosis teams across the country, we have produced evidence based prescribing guidelines to ensure that these vulnerable patients are not prescribed medication unnecessarily, are included in prescribing decisions, and therefore more likely to take medication, and that we choose medications which will have fewer side effects or long term physical health effects,”
Dr Liz Ewins was on hand at the virtual event to present their winning example along with her fellow finalists. The three finalists were chosen from a list of 20 highly commended examples which can all be found on the NICE website.
The runners up were:
- Bronchiolitis: when less is more, from the Maynard Sinclair Ward, Ulster Hospital, South Eastern Health and Social Care Trust Northern Ireland
- East of England Stroke Telemedicine Partnership
This year, the awards event also highlighted two excellent examples of how our rapid guidelines or other NICE guidance have been used to help continue the care of people and resume services during COVID-19. These examples were:
- Developing and implementing guidance for staff who delegated clinical tasks to informal carers and relatives from Livewell Southwest
- Delivering a paediatric elective surgery service during the COVID-19 pandemic from Bedfordshire Hospitals NHS Foundation Trust
Submissions for next year’s Shared Learning Awards are now open so please visit the NICE website to find out more.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
Children and young people need accurate, accessible information about their healthcare05/03/2021 11:25:00
New draft guidance from NICE published today recommends ensuring children and young people are fully informed about their health so that they are empowered to take an active role in their healthcare
Register now for the HTAi 2021 Virtual Annual Meeting05/03/2021 11:15:00
The Health Technology Assessment International (HTAi) 2021 Annual Meeting will be held virtually from 19-23 June 2021, and registration is now open.
Thousands of breast cancer patients to have routine access to NICE-approved drug combination01/03/2021 15:28:15
Another potentially life-extending drug combination for some people with advanced breast cancer will now be available for routine use after draft guidance from NICE recommended ribociclib (also called Kisqali and made by Novartis) is taken out of the Cancer Drugs Fund (CDF).
Hundreds of people set to benefit as NICE recommends selective internal radiation therapy for treating advanced liver cancer26/02/2021 16:15:00
Hundreds of people with advanced liver cancer (also called hepatocellular carcinoma or HCC) are set to benefit after NICE today (26 February 2021) published final draft guidance recommending a cancer treatment called selective internal radiation therapy (SIRT) as an option for treating the condition.
NHS patients to benefit from first full access deal in Europe for new CAR-T therapy recommended by NICE25/02/2021 15:20:00
NICE has agreed a managed access agreement, via the Cancer Drugs Fund with manufacturer Kite, so more data can be collected while patients can access the treatment.
NICE draft guidance recommends sapropterin for children with rare inherited metabolic condition phenylketonuria25/02/2021 14:15:00
NICE has today (25 February 2021) issued draft guidance for public consultation which recommends sapropterin (also called Kuvan and made by BioMarin) for treating phenylketonuria (PKU) in children aged up to 18.
A new instrument for consideration of a broader range of benefits for people, their families and carers18/02/2021 14:15:00
Blog posted by: Bhash Naidoo Senior Technical Adviser – Health Economics at NICE, 17 February 2021.
Skin cancer drug recommended for routine NHS use15/02/2021 09:15:00
An appeal period has now opened until 26 February 2021.
NICE recommends treatment options for severe pregnancy sickness in new draft guidance11/02/2021 15:15:00
Nausea and vomiting, often referred to as morning sickness, is common in pregnancy. Close to 80% of pregnant women experience these symptoms, with most conditions improving or stopping completely by around 16 to 20 weeks